116 related articles for article (PubMed ID: 22236991)
21. [Chronic myeloid leukemia: a decade of progress].
Cervantes F
Med Clin (Barc); 1990 Jan; 94(1):27-35. PubMed ID: 1692385
[No Abstract] [Full Text] [Related]
22. [Demonstration of BCR-ABL rearrangement in a patient with apparently Ph-negative chronic myeloid leukemia of 15 years' duration].
Valiente A; Outeriño J; Martín Calderín F; Benítez J
Sangre (Barc); 1990 Dec; 35(6):481-3. PubMed ID: 2087668
[TBL] [Abstract][Full Text] [Related]
23. [Molecular biology of chronic myeloid leukemia].
Hellmann A
Acta Haematol Pol; 1992; 23(2 Suppl 1):13-7. PubMed ID: 1488867
[TBL] [Abstract][Full Text] [Related]
24. Outcome of treatment in adults with Philadelphia chromosome-positive and/or BCR-ABL--positive acute lymphoblastic leukemia-retrospective analysis of Polish Adult Leukemia Group (PALG).
Wrzesień-Kuś A; Robak T; Pluta A; Zwolińska M; Wawrzyniak E; Wierzbowska A; Skotnicki A; Jakubas B; Hołowiecki J; Nowak K; Kuliczkowski K; Mazur G; Haus O; Dmoszyńska A; Adamczyk-Cioch M; Jedrzejczak WW; Paluszewska M; Konopka L; Pałynyczko G
Ann Hematol; 2006 Jun; 85(6):366-73. PubMed ID: 16523310
[TBL] [Abstract][Full Text] [Related]
25. Myeloid mixed chimerism is associated with relapse in bcr-abl positive patients after unmanipulated allogeneic bone marrow transplantation for chronic myelogenous leukemia.
Román J; Serrano J; Jiménez A; Castillejo JA; Reina ML; González MG; Rodríguez MC; García I; Sánchez J; Maldonado J; Torres A
Haematologica; 2000 Feb; 85(2):173-80. PubMed ID: 10681725
[TBL] [Abstract][Full Text] [Related]
26. Severe oral chronic graft-versus-host disease following allogeneic bone marrow transplantation: highly effective treatment with topical tacrolimus.
Eckardt A; Starke O; Stadler M; Reuter C; Hertenstein B
Oral Oncol; 2004 Sep; 40(8):811-4. PubMed ID: 15288836
[TBL] [Abstract][Full Text] [Related]
27. Karyotype and BCR studies after bone marrow transplantation for chronic myeloid leukaemia.
Ruutu T; Peltomäki P; Volin L; Lindlöf M; Knuutila S
Bone Marrow Transplant; 1991; 7 Suppl 2():20. PubMed ID: 1878697
[No Abstract] [Full Text] [Related]
28. p190 bcr-abl rearrangement: a secondary cytogenetic event in some chronic myeloid disorders?
Roumier C; Daudignon A; Soenen V; Dupriez B; Wetterwald M; Lai JL; Cosson A; Fenaux P; Preudhomme C
Haematologica; 1999 Dec; 84(12):1075-80. PubMed ID: 10586207
[TBL] [Abstract][Full Text] [Related]
29. [Molecular basis of chronic myelogenous leukemia and significance of diagnostic methods based on BCR-ABL gene amplification].
Sacha T; Dulak J; Skotnicki AB; Dembińska-Kiec A
Przegl Lek; 1999; 56 Suppl 1():57-61. PubMed ID: 10494184
[TBL] [Abstract][Full Text] [Related]
30. Philadelphia chromosome-positive thrombocythemia without features of chronic myeloid leukemia (CML) in peripheral blood.
Girodon F; Bailly F; Barry M; Favre B; Carli PM; Mugneret F; Teyssier JR; Maynadié M
Ann Hematol; 2005 Jun; 84(6):409-10. PubMed ID: 15692837
[No Abstract] [Full Text] [Related]
31. Generation of the BCR/ABL fusion gene in a Philadelphia chromosome-negative chronic myeloid leukaemia: insertion of 5.6 Mb of 9q34 into the BCR region of chromosome 22.
Valle L; Fernández V; Pérez-Pons C; Sánchez FG; Benítez J; Urioste M
Hematol Oncol; 2006 Jun; 24(2):86-8. PubMed ID: 16598834
[TBL] [Abstract][Full Text] [Related]
32. Clinical use of the bcr/abl probe test in the evaluation of chronic myeloid leukemia patients.
Yazici H; Sengün Z; Aktan M; Aktuglu G; Uskent N; Dalay N
J Exp Clin Cancer Res; 1997 Mar; 16(1):105-9. PubMed ID: 9148870
[TBL] [Abstract][Full Text] [Related]
33. [Autogeneic peripheral blood hemopoietic stem cell transplantation for chronic myeloid leukemia with imatinib mesylate-induced negative Philadelphia chromosome].
Meng FY; Sun J; Liu QF; Xu D; Yang LJ; Song LL; Liu XL; Xu B; Zhou SY
Di Yi Jun Yi Da Xue Xue Bao; 2003 Dec; 23(12):1301-2, 1306. PubMed ID: 14678896
[TBL] [Abstract][Full Text] [Related]
34. [The Philadelphia chromosome 30 years later].
Lisker R
Rev Invest Clin; 1992; 44(1):123-30. PubMed ID: 1523343
[TBL] [Abstract][Full Text] [Related]
35. Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome.
Druker BJ; Sawyers CL; Kantarjian H; Resta DJ; Reese SF; Ford JM; Capdeville R; Talpaz M
N Engl J Med; 2001 Apr; 344(14):1038-42. PubMed ID: 11287973
[TBL] [Abstract][Full Text] [Related]
36. Antisense inhibition of P210 bcr-abl in chronic myeloid leukemia.
Vaerman JL; Lewalle P; Martiat P
Stem Cells; 1993 Oct; 11 Suppl 3():89-95. PubMed ID: 8298481
[TBL] [Abstract][Full Text] [Related]
37. Allogeneic transplantation: a therapeutic option for myelofibrosis, chronic myelomonocytic leukemia and Philadelphia-negative/BCR-ABL-negative chronic myelogenous leukemia.
Mittal P; Saliba RM; Giralt SA; Shahjahan M; Cohen AI; Karandish S; Onida F; Beran M; Champlin RE; de Lima M
Bone Marrow Transplant; 2004 May; 33(10):1005-9. PubMed ID: 15048141
[TBL] [Abstract][Full Text] [Related]
38. [Pathogenesis and pathophysiology of chronic myeloid leukemia in chronic phase].
Hirase C; Matsumura I
Nihon Rinsho; 2012 Apr; 70 Suppl 2():293-7. PubMed ID: 23133970
[No Abstract] [Full Text] [Related]
39. Pediatric secondary chronic myeloid leukemia following cardiac transplantation for anthracycline-induced cardiomyopathy.
Menon NM; Katsanis E; Khalpey Z; Whitlow P
Pediatr Blood Cancer; 2015 Jan; 62(1):166-8. PubMed ID: 25175922
[TBL] [Abstract][Full Text] [Related]
40. P190
Wang H; Wang ZY; Xin CH; Shang YH; Jing R; Yan FH; Feng SZ
Chin Med J (Engl); 2017 Feb; 130(4):495-496. PubMed ID: 28218227
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
